Supplemental material
Drug Delivery
Volume 25, 2018 - Issue 1
Open access
5,244
Views
44
CrossRef citations to date
0
Altmetric
Research Article
Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer
Yiwen YouSchool of Pharmacy, Nanjing Medical University, Nanjing, China; View further author information
, Zhiyuan XuSchool of Pharmacy, Nanjing Medical University, Nanjing, China; View further author information
& Yun ChenSchool of Pharmacy, Nanjing Medical University, Nanjing, China; ;State Key Laboratory of Reproductive Medicine, Nanjing, ChinaCorrespondence[email protected]
View further author information
View further author information
Pages 448-460
|
Received 02 Nov 2017, Accepted 29 Jan 2018, Published online: 06 Feb 2018
Related Research Data
Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer
Source:
Figshare
Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer
Source:
Figshare
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.